# DESCRIPTION

## TECHNICAL FIELD

- relate to rheumatoid arthritis diagnosis

## BACKGROUND ART

- introduce rheumatoid arthritis and miRNA

## SUMMARY OF THE INVENTION

### Problems to be Solved by the Invention

- identify limitations of current diagnosis methods

### Means of Solving the Problems

- study miRNA concentration in plasma
- identify miRNAs with high expression levels
- evaluate sensitivity and specificity of miRNAs
- compare with conventional markers
- study correlation with disease state
- identify miRNAs as disease state markers
- develop composite value of miRNAs
- evaluate performance of composite value
- complete the invention

### Effect of the Invention

- enable early diagnosis of rheumatoid arthritis

## DESCRIPTION OF EMBODIMENTS

### 1. Test Method of a Sample Derived From the Blood of a Test Subject for Determining the Pathology of Rheumatoid Arthritis

- introduce test method for rheumatoid arthritis
- describe step (a) of measuring miRNA expression levels
- specify miRNAs to be measured
- explain normalization of expression levels
- describe determination of pathology of rheumatoid arthritis
- specify test subjects
- describe sample preparation
- explain measurement of miRNA expression levels
- specify internal standard miRNA
- describe extraction of RNA containing miRNA
- explain isolation of miRNA
- describe normalization of expression levels using internal standard
- specify nucleic acid probe and primer
- explain hybridization conditions
- describe design of nucleic acid probe and primer
- explain labeling of nucleic acid probe and primer
- define nucleic acid probe and primer
- describe derivatives of nucleic acid
- explain synthesis of nucleic acid probe and primer
- describe nucleic acid array
- introduce method of present invention
- correlate expression level with pathology of rheumatoid arthritis
- describe determination of rheumatoid arthritis
- establish correlation between expression level and pathology
- describe calculation of cutoff value
- describe determination of state of disease
- describe measurement of expression level of multiple miRNAs
- describe calculation of composite value
- describe combination of miRNA expression level and anti-CCP antibody level
- describe measurement of anti-CCP antibody level
- describe correlation with pathology of rheumatoid arthritis
- describe treatment based on determination of rheumatoid arthritis

### 2. Diagnostic Reagent for Determining the Pathology of Rheumatoid Arthritis

- define diagnostic reagent
- specify nucleic acid probes or primers
- describe nucleic acid array embodiment
- outline reagent preparation and storage
- specify additional components for measurement methods
- describe additional components for anti-CCP antibody level measurement

## EXAMPLES

- describe experimental methods

### Method

- prepare plasma sample
- prepare total RNA
- isolate miRNA
- perform miRNA array analysis

### Results

- summarize miRNA array results
- identify candidate diagnosis markers
- analyze expression levels of miRNAs
- calculate prediction values for RA prediction

## COMPARATIVE EXAMPLE

- compare miRNA expression levels in osteoarthritis and systemic lupus erythematosus

## INDUSTRIAL APPLICABILITY

- describe industrial applicability of diagnostic method

